BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29667728)

  • 21. Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial.
    Heerfordt IM; Wulf HC
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2058-2061. PubMed ID: 31197894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global verification of a model for determining daylight photodynamic therapy dose.
    O'Mahoney P; Khazova M; LaRochelle E; Pogue B; Ibbotson SH; Eadie E
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102260. PubMed ID: 33781909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy with delta-aminolevulinic acid and light-emitting diodes in actinic keratosis.
    Ritter CG; Kuhl IC; Lenhardt C; Weissbluth ML; Bakos RM
    An Bras Dermatol; 2010; 85(5):639-45. PubMed ID: 21152788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New aspects in photodynamic therapy of actinic keratoses.
    Smits T; Moor AC
    J Photochem Photobiol B; 2009 Sep; 96(3):159-69. PubMed ID: 19592269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
    Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.
    Tzogani K; Straube M; Hoppe U; Kiely P; O'Dea G; Enzmann H; Salmon P; Salmonson T; Pignatti F
    J Dermatolog Treat; 2014 Oct; 25(5):371-4. PubMed ID: 23550714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
    Neittaanmäki-Perttu N; Grönroos M; Tani T; Snellman E
    Acta Derm Venereol; 2016 Jun; 96(5):712-3. PubMed ID: 26806126
    [No Abstract]   [Full Text] [Related]  

  • 32. Photodynamic therapy with the use of superluminescent diodes (sLED) in the treatment of actinic keratosis.
    Bartosińska J; Wolska-Gawron K; Gerkowicz A; Niewiedzioł M; Michalska-Jakubus M; Komza M; Klepaczewski T; Kwaśny M; Krasowska D
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():187-190. PubMed ID: 29684690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daylight photodynamic therapy - Experience and safety in treatment of actinic keratoses of the face and scalp in low latitude and high brightness region.
    Galvão LE; Gonçalves HS; Botelho KP; Caldas JC
    An Bras Dermatol; 2017; 92(1):142-144. PubMed ID: 28225978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-Step Irradiance Treatment Can Achieve Excellent Pain Control During Red Light 5-Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses.
    Paragh G; Zeitouni NC
    Photomed Laser Surg; 2018 Mar; 36(3):174-176. PubMed ID: 29227199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison.
    LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDT with PPIX absorption peaks adjusted wavelengths: Safety and efficacy of a new irradiation procedure for actinic keratoses on the head.
    von Dobbeler C; Schmitz L; Dicke K; Szeimies RM; Dirschka T
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():198-202. PubMed ID: 31176762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
    Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
    Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
    Mei X; Wang L; Zhang R; Zhong S
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():23-28. PubMed ID: 30412779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
    Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.